[Influencing the effect of epicutaneously applied trypsin by means of a trypsin inhibitor and dermatologic pretreatment of the human skin in vivo].
D007611:Aprotinin / Q000627:therapeutic use*; D003033:Coal Tar / Q000494:pharmacology; D003879:Dermatologic Agents / Q000494:pharmacology*; D004890:Erythema / Q000139:chemically induced; D006801:Humans; D007271:Injections, Intradermal; D007279:Injections, Subcutaneous; D009638:Norepinephrine / Q000494:pharmacology; D010577:Petrolatum / Q000494:pharmacology; D011292:Premedication; D012867:Skin / Q000187:drug effects*; D014221:Triamcinolone / Q000494:pharmacology; D014357:Trypsin / Q000009:adverse effects*; D014466:Ultraviolet Rays
D003879:Dermatologic Agents; D014221:Triamcinolone; D003033:Coal Tar; D010577:Petrolatum; D007611:Aprotinin; D014357:Trypsin; D009638:Norepinephrine
Beeinflussung der Wirkung epicutan applizierten Trypsins durch Trypsininhibitor und dermatologische Vorbehandlung der menschlichen Haut in vivo.